Healthcare Professional? Make a Referral!
For people living with difficult-to-treat depression, when two or more antidepressants have not provided relief, Spravato® (esketamine) offers an alternative that works differently from traditional…
The FDA recently cleared Spravato® as the first nasal spray for difficult to treat depression, proving high effectiveness when other medications haven’t worked. Spravato® doesn’t…
More than 21 million adults in the United States experienced a major depressive episode in 2021, and over 30% of those people didn’t respond well…
Treatment-resistant depression (TRD) is typically diagnosed when someone has tried two or more antidepressant medications without experiencing significant improvements in symptoms. This can be frustrating…
Spravato®, a form of esketamine, is a prescription nasal spray that has been approved by the FDA for difficult-to-treat depression. Spravato® works differently than traditional…
For some adults living with depression, even the best treatments can fall short. You may try several antidepressants, follow every step of your provider’s plan,…
Depression can feel like it takes away your energy, your joy, and even your hope for the future. For many adults, standard antidepressants are not…
Finding the right treatment for depression can be deeply personal, and for some, it’s not as simple as starting a new medication or attending therapy.…
When navigating depression, finding effective treatment options can feel overwhelming—especially when traditional methods haven’t worked. If you’ve been struggling to manage symptoms of depression, Spravato®…
Feeling better is possible with this leading-edge treatment. Are you or a loved one struggling with treatment-resistant depression (TRD) in Massachusetts? Relief may be closer…
